top of page
Search

Cardiovascular Disease Prevention Using Stem Cell Therapy

Edited by Nabiha Kashfee

--

This blog post serves to simplify the following scholarly article:


Heart failure affects millions of people worldwide each year. But what if instead of only treating the damage, we could repair the heart itself? Rather than permanent scar formation, damaged heart tissue could regenerate. This possibility shows how the future of modern medicine may lie in stem cell therapy.


Stem cells are precursor cells that can differentiate into multiple specialized cell types. Their ability to regenerate has been advanced with the help of artificial intelligence (AI) and machine learning (ML), which help enhance their use in treating heart failure.   



Physiology of the Heart

To understand the role of stem cell therapy, it is important to first examine the function of the heart and the development of heart failure. The heart moves blood and oxygen throughout the body and delivers nutrients to cells while transporting waste to other organs that can filter and cleanse the body. By consistently supplying oxygenated blood throughout the body, the heart maintains a healthy blood pressure.


What is Heart Failure (HF)

Heart failure (HF) occurs when the heart becomes too stiff or weak to pump enough oxygen-rich blood to meet the body’s needs. Reduced pumping capacity can lead to serious complications and even death. Chronic conditions like cardiomyopathy (disease of the heart that affects how well your heart can pump blood) often contribute to HF, which is largely irreversible due to the limited regenerative capacity to restore severe myocardial (heart muscle) damage. HF is very prevalent in society as 1 in 4 adults are estimated to develop it.

HF can be classified as ischemic and non-ischemic. Ischemic HF results from reduced or blocked blood flow and oxygen supply, usually due to coronary artery disease. Non-ischemic HF happens due to other causes that could be genetic or a result of infections. A major cause of ischemic damage is Myocardial Infarction (MI), commonly known as a heart attack. MI occurs when a coronary artery is suddenly blocked, cutting off oxygen to the heart and resulting in tissue death.  



Traditional Methods of treating Heart Failure  

Traditional treatments for treating HF focus more on alleviating symptoms rather than repair. Vasodilators and beta-blockers reduce blood pressure and cardiac stress, while diuretics and mineralocorticoid receptor antagonists decrease fluid retention. Sodium- glucose cotransporter-2 (SGLT2) inhibitors reduce glucose levels and fluid buildup. In advanced stages, heart transplants or mechanical support devices may be required. However, these approaches have significant limitations: they do not regenerate damaged heart tissue, may lose effectiveness over time, and can cause side effects such as fatigue, kidney dysfunction, and electrolyte imbalances. Among these complications, transplants are restricted by donor availability and patient eligibility. 


Application to HF– Exosomal Therapy 

Given the limitations of traditional treatments, regenerative therapies have shown to be a more promising alternative. One approach is exosomal therapy, which uses small vesicles called exosomes to promote cellular repair. Exosomes are membrane-bound vesicles, released by cells that carry proteins, lipids, and genetic material for cell-to-cell communication. 

A key source of these exosomes are cardiosphere-derived cells (CDCs), a type of stem cell derived from the heart tissue. These cells are able to form clusters that have the ability to promote cardiac repair. CDCs release exosomes that contain signaling molecules, helping reduce inflammation, prevent cell death, and promote tissue regeneration. These effects are important for cardiomyocytes, the muscle cells that are responsible for the contraction of the heart, and  for mesenchymal cells, which are cells involved in tissue repair and structural stability. In HF, cardiomyocytes are damaged, and mesenchymal cells may contribute to scar formation. Exosomal signaling helps protect cells and improves their function. 


Exosomal Therapy: How it Works

To deliver these therapies, techniques such as intramyocardial injections are used, where cells or exosomes are injected directly into the heart. This delivery allows for a higher concentration of regenerative material to reach the damaged area, improving effectiveness. 

Building on this, stem cell therapy aims to restore the heart’s function by introducing regenerative cells into damaged regions of the heart. Once delivered, these cells support repair through paracrine signaling, releasing chemical signals that reduce inflammation, stimulate repair, and prevent further cell death. Stem cells also promote angiogenesis, the formation of new blood vessels, improving oxygen supply to the heart tissue. Additionally, they support cardiac remodeling, reduce scar tissue and improve the elasticity and function of the heart. Exosomal therapy enhances these processes by improving the communication between the cells. Cardiomyocytes and blood vessel cells take up the exosomes, and influence gene expression and activate repair pathways. This reduces apoptosis (cell death), limits fibrosis (scar formation), and helps maintain the heart’s ability to contract effectively.  



Challenges in current clinical application

Despite its potential, stem cell therapy faces several limitations. Differences between animal models and human physiology can reduce the effectiveness of treatments. Additionally, laboratory conditions do not fully replicate the complex environment of the human body, such as genetics, diet, and disease progression. 

Treatment effectiveness also depends on variables such as dosage, delivery methods, and duration. Within the damaged heart, harsh conditions– including ischemia, inflammation, and fibrosis– can reduce stem cell survival, proliferation, and signaling ability. Furthermore, patient variability makes it difficult to predict who will benefit the most from therapy. 


Future Steps


Medicine is constantly evolving to better meet patient needs, and stem cell therapy is at the forefront of this change. Precision medicine hopes to individualize treatments, tailoring the therapies to each patient’s condition. Artificial Intelligence (AI) and Machine Learning (ML) optimize cell culture environments, stimulating growth, and improving survival rates. Through the use of AI with regenerative therapies, treatments can become more personalized and effective. Ultimately, the integrations of AI and machine learning with stem cell therapy can allow for more personalized and effective treatments overall increasing the impact of stem cell therapy.

bottom of page